NLS Pharmaceutics (NLSP) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
NLS Pharmaceutics has announced a merger with Israeli-based Kadimastem Ltd., aiming to strengthen its position in the pharmaceutical market. This strategic move will result in Kadimastem becoming a wholly owned subsidiary of NLS Pharmaceutics, potentially offering new opportunities for investors. The merger also involves the distribution of contingent value rights to NLS shareholders, tied to the future sale of legacy assets.
For further insights into NLSP stock, check out TipRanks’ Stock Analysis page.
